Latisse Ingredients Evaluated as Possible Hair Loss Treatment
Allergan Inc reportedly began clinical trials of bimatoprost solution in October, testing new formulations as a potential hair loss treatment. Bimatoprost, is the growth-stimulating ingredient in the popular eyelash medication Latisse. According to the website clinicaltrials.gov, the trial will evaluate “the safety, tolerability and...
View More